The World Health Organization (WHO) estimates an annual occurrence of 300-500 million cases of malaria worldwide. The toll is the highest in developing countries where at least one million people die from the disease. Young children account for most of these deaths.

Moreover, malaria is a great drain on many national economies. Many economists believe that malaria is responsible for a ‘growth penalty’ of up to 1.3% per year in some countries. Since the disease is widely prevalent in the less developed countries, this leads to a vicious cycle of disease and poverty.
                       
The PermaNet® technology, developed by Vestergaard Frandsen and patented in many countries, combats malaria with the use of insecticidal bednets. This superior technology controls the slow release and migration of the WHO-approved insecticide in the yarn to the surface of the netting, resulting in long-lasting efficacy even after multiple washes.

With insecticide resistance emerging as a serious public health crisis, newer ways of combating this disease have to be put in place. Insecticide resistant mosquitoes are able to overcome the insecticide by developing changes in their metabolic system and/ or to the target site where the insecticide binds.

PermaNet® 3.0 Combination Net (CN) has been developed as the world’s first new generation long-lasting insecticidal net (LN) that has increased efficacy against pyrethroid-resistant malaria vectors. Superior PermaNet® 3.0 technology enables sustained effectiveness of pyrethroids, rapid regeneration of insecticide even after multiple washes and a unique wall construction leading to enhanced lifetime of the net. This ensures that PermaNet® 3.0 kills both susceptible and pyrethroid-resistant malaria vectors.

With the new PermaNet® 3.0 technology, Vestergaard Frandsen is committed to investing in products that will protect the most vulnerable members of society.